Analyst Price Target is $12.33
▲ +156.41% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Dermata Therapeutics in the last 3 months. The average price target is $12.33, with a high forecast of $14.00 and a low forecast of $9.00. The average price target represents a 156.41% upside from the last price of $4.81.
Current Consensus is
The current consensus among 3 polled investment analysts is to buy stock in Dermata Therapeutics.